Estrogenic Substance
Estrogenic Substance Brand names, Estrogenic Substance Analogs
- Aquacrine
- Crinovaryl
- Cristallovar
- Crystogen
- Destrone
- Disynformon
- Endofolliculina
- Esterone
- Estrin
- Estrogenic Substance
- Estrol
- Estron
- Estrona
- Estrona [Inn-Spanish]
- Estrona [Spanish]
- Estrone [Usan:Inn]
- Estrone-A
- Estronum [Inn-Latin]
- Estrovarin
- Estrugenone
- Estrusol
- Femestrone Inj.
- Femestrone Injection
- Femidyn
- Fermidyn
- Folikrin
- Folipex
- Folisan
- Follestrine
- Follestrol
- Follicular Hormone
- Folliculin
- Folliculine
- Folliculine Benzoate
- Follicunodis
- Follidrin
- GSS 33
- Glandubolin
- Hiestrone
- Hormestrin
- Hormofollin
- Hormovarine
- Kestrone
- Ketodestrin
- Ketohydroxy-Estratriene
- Ketohydroxyestrin
- Ketohydroxyoestrin
- Ketophydroxyestrin
- Kolpon
- Menagen
- Menformon
- Menformon A
- Mestronaq
- OVEX
- Oestrin
- Oestroform
- Oestrone
- Oestrone [Steroidal Oestrogens]
- Oestronum
- Oestroperos
- Ovifollin
- Penncap M
- Perlatan
- Sinafid M-48
- Solliculin
- Theelin
- Thelestrin
- Thelykinin
- Thynestron
- Tokokin
- Unden
- Wynestron
- Wynestronpencap M
Estrogenic Substance Brand Names Mixture
- Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
- Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)
Estrogenic Substance Chemical_Formula
C18H22O2
Estrogenic Substance RX_link
No information avaliable
Estrogenic Substance fda sheet
Estrogenic Substance msds (material safety sheet)
Estrogenic Substance Synthesis Reference
G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)
Estrogenic Substance Molecular Weight
270.366 g/mol
Estrogenic Substance Melting Point
254.5-256 oC
Estrogenic Substance H2O Solubility
3 g/100mL
Estrogenic Substance State
Solid
Estrogenic Substance LogP
4.067
Estrogenic Substance Dosage Forms
Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension
Estrogenic Substance Indication
For management of Menopausal and postmenopausal disorders
Estrogenic Substance Pharmacology
Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.
Estrogenic Substance Absorption
43%
Estrogenic Substance side effects and Toxicity
Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.
Estrogenic Substance Patient Information
Estrogenic Substance Organisms Affected
Humans and other mammals
